Početna stranicaTAK • NYSE
add
Takeda Pharmaceutical Company
14,44 $
Poslije radnog vremena:(0,97 %)−0,14
14,30 $
Zatvoreno: 8. kol, 19:56:15 GMT -4 · USD · NYSE · Odricanje od odgovornosti
Preth. zaklj. cijena
14,36 $
Dnevni raspon
14,38 $ - 14,49 $
Godišnji raspon
12,80 $ - 15,53 $
Tržišna kapitalizacija
45,93 mlr. USD
Prosječna količina
4,53 mil.
P/E omjer
49,23
Prinos dividende
4,61 %
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (JPY) | lip 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 1,11 bil. | −8,39 % |
Operativni troškovi | 535,14 mlr. | −15,12 % |
Neto dohodak | 124,24 mlr. | 30,44 % |
Neto profitabilnost | 11,23 | 42,51 % |
Zarada po dionici | — | — |
EBITDA | 368,50 mlr. | −3,72 % |
Efektivna porezna stopa | 17,49 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (JPY) | lip 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 350,01 mlr. | −56,48 % |
Ukupna imovina | 14,00 bil. | −13,70 % |
Ukupne obveze | 7,14 bil. | −15,31 % |
Ukupni kapital | 6,87 bil. | — |
Dionice u optjecaju | 1,56 mlr. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,00 | — |
Povrat imovine | 3,31 % | — |
Povrat kapitala | 3,90 % | — |
Tok novca
Neto promjena novca
| (JPY) | lip 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 124,24 mlr. | 30,44 % |
Gotovina od poslovanja | 215,42 mlr. | 26,49 % |
Gotovina iz ulaganja | −33,19 mlr. | 78,82 % |
Gotovina iz financiranja | −214,90 mlr. | −167,92 % |
Neto promjena novca | −35,10 mlr. | −110,11 % |
Slobodan tok novca | 99,91 mlr. | −14,31 % |
Više
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
Glavni izvršni direktor
Osnovano
12. lip 1781.
Web-lokacija
Zaposlenici
47.455
